Cargando…
A pilot study to assess the effect of a three-month vitamin supplementation containing L-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes
PURPOSE: The aim of the present study was to investigate the effect of a three-month dietary supplementation with a methylfolate formulation on homocysteine plasma concentrations and ocular blood flow parameters in patients with diabetes. METHODS: Twenty-four patients with diabetes received a dietar...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190578/ https://www.ncbi.nlm.nih.gov/pubmed/32355442 |
_version_ | 1783527710387077120 |
---|---|
author | Schmidl, Doreen Howorka, Kinga Szegedi, Stephan Stjepanek, Kristina Puchner, Stefan Bata, Ahmed Scheschy, Ulrike Aschinger, Gerold Werkmeister, René M. Schmetterer, Leopold Garhofer, Gerhard |
author_facet | Schmidl, Doreen Howorka, Kinga Szegedi, Stephan Stjepanek, Kristina Puchner, Stefan Bata, Ahmed Scheschy, Ulrike Aschinger, Gerold Werkmeister, René M. Schmetterer, Leopold Garhofer, Gerhard |
author_sort | Schmidl, Doreen |
collection | PubMed |
description | PURPOSE: The aim of the present study was to investigate the effect of a three-month dietary supplementation with a methylfolate formulation on homocysteine plasma concentrations and ocular blood flow parameters in patients with diabetes. METHODS: Twenty-four patients with diabetes received a dietary supplement (Oculofolin, Aprofol AG, Switzerland) containing 900 µg L‑methylfolate (levomefolate calcium or [6S]-5-methyltetrahydrofolic acid, calcium salt), methylcobalamin, and other ingredients for three consecutive months. The patients’ plasma homocysteine concentration and retinal blood flow were assessed at baseline and after three months of folate intake. Retinal blood flow was measured using a custom-built dual-beam Doppler optical coherence tomography (OCT) system. In addition, flicker-induced retinal vasodilatation was assessed by means of a commercially available dynamic vessel analyzer (IMEDOS, Jena, Germany). RESULTS: Supplementation was well tolerated by all patients. After three months, plasma homocysteine concentration significantly decreased from 14.2 ± 9.3 to 9.6 ± 6.6 µmol/L (p < 0.001). In addition, a tendency toward an increased total retinal blood flow from 36.8 ± 12.9 to 39.2 ± 10.8 µl/min was observed, but this effect did not reach the level of significance (p = 0.11). Supplementation had no effect on retinal vessel diameter or flicker-induced vasodilatation. CONCLUSIONS: The present data show that a three-month intake of a dietary supplement containing methylfolate can significantly reduce blood homocysteine levels in patients with diabetes. This is of importance because higher homocysteine plasma levels have been found to be associated with an increased risk of vascular associated systemic diseases and eye diseases. Whether systemic methylfolate supplementation affects retinal perfusion must be studied in a larger population. |
format | Online Article Text |
id | pubmed-7190578 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Molecular Vision |
record_format | MEDLINE/PubMed |
spelling | pubmed-71905782020-04-30 A pilot study to assess the effect of a three-month vitamin supplementation containing L-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes Schmidl, Doreen Howorka, Kinga Szegedi, Stephan Stjepanek, Kristina Puchner, Stefan Bata, Ahmed Scheschy, Ulrike Aschinger, Gerold Werkmeister, René M. Schmetterer, Leopold Garhofer, Gerhard Mol Vis Research Article PURPOSE: The aim of the present study was to investigate the effect of a three-month dietary supplementation with a methylfolate formulation on homocysteine plasma concentrations and ocular blood flow parameters in patients with diabetes. METHODS: Twenty-four patients with diabetes received a dietary supplement (Oculofolin, Aprofol AG, Switzerland) containing 900 µg L‑methylfolate (levomefolate calcium or [6S]-5-methyltetrahydrofolic acid, calcium salt), methylcobalamin, and other ingredients for three consecutive months. The patients’ plasma homocysteine concentration and retinal blood flow were assessed at baseline and after three months of folate intake. Retinal blood flow was measured using a custom-built dual-beam Doppler optical coherence tomography (OCT) system. In addition, flicker-induced retinal vasodilatation was assessed by means of a commercially available dynamic vessel analyzer (IMEDOS, Jena, Germany). RESULTS: Supplementation was well tolerated by all patients. After three months, plasma homocysteine concentration significantly decreased from 14.2 ± 9.3 to 9.6 ± 6.6 µmol/L (p < 0.001). In addition, a tendency toward an increased total retinal blood flow from 36.8 ± 12.9 to 39.2 ± 10.8 µl/min was observed, but this effect did not reach the level of significance (p = 0.11). Supplementation had no effect on retinal vessel diameter or flicker-induced vasodilatation. CONCLUSIONS: The present data show that a three-month intake of a dietary supplement containing methylfolate can significantly reduce blood homocysteine levels in patients with diabetes. This is of importance because higher homocysteine plasma levels have been found to be associated with an increased risk of vascular associated systemic diseases and eye diseases. Whether systemic methylfolate supplementation affects retinal perfusion must be studied in a larger population. Molecular Vision 2020-04-24 /pmc/articles/PMC7190578/ /pubmed/32355442 Text en Copyright © 2020 Molecular Vision. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited, used for non-commercial purposes, and is not altered or transformed. |
spellingShingle | Research Article Schmidl, Doreen Howorka, Kinga Szegedi, Stephan Stjepanek, Kristina Puchner, Stefan Bata, Ahmed Scheschy, Ulrike Aschinger, Gerold Werkmeister, René M. Schmetterer, Leopold Garhofer, Gerhard A pilot study to assess the effect of a three-month vitamin supplementation containing L-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes |
title | A pilot study to assess the effect of a three-month vitamin supplementation containing L-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes |
title_full | A pilot study to assess the effect of a three-month vitamin supplementation containing L-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes |
title_fullStr | A pilot study to assess the effect of a three-month vitamin supplementation containing L-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes |
title_full_unstemmed | A pilot study to assess the effect of a three-month vitamin supplementation containing L-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes |
title_short | A pilot study to assess the effect of a three-month vitamin supplementation containing L-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes |
title_sort | pilot study to assess the effect of a three-month vitamin supplementation containing l-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190578/ https://www.ncbi.nlm.nih.gov/pubmed/32355442 |
work_keys_str_mv | AT schmidldoreen apilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes AT howorkakinga apilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes AT szegedistephan apilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes AT stjepanekkristina apilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes AT puchnerstefan apilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes AT bataahmed apilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes AT scheschyulrike apilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes AT aschingergerold apilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes AT werkmeisterrenem apilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes AT schmettererleopold apilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes AT garhofergerhard apilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes AT schmidldoreen pilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes AT howorkakinga pilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes AT szegedistephan pilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes AT stjepanekkristina pilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes AT puchnerstefan pilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes AT bataahmed pilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes AT scheschyulrike pilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes AT aschingergerold pilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes AT werkmeisterrenem pilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes AT schmettererleopold pilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes AT garhofergerhard pilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes |